Stay updated on Secukinumab Efficacy in Atopic Dermatitis Clinical Trial

Sign up to get notified when there's something new on the Secukinumab Efficacy in Atopic Dermatitis Clinical Trial page.
Latest website image capture
Clouds background image

Latest updates to the Secukinumab Efficacy in Atopic Dermatitis Clinical Trial page

  1. Check
    today
    No Change Detected
  2. Check
    yesterday
    No Change Detected
  3. Check
    2 days ago
    Change Detected
    Summary
    The value of Revision has been updated from v2.8.0 to v2.8.1, indicating a recent revision in the content of the webpage.
    Difference
    0.1%
    Check dated 2024-06-13T21:50:30.000Z thumbnail image
  4. Check
    3 days ago
    No Change Detected
  5. Check
    5 days ago
    No Change Detected
  6. Check
    10 days ago
    Change Detected
    Summary
    The value on the webpage has changed from 7 to 8, indicating a potential update or revision in the study details related to the investigation of the efficacy of Secukinumab in patients with moderate to severe atopic dermatitis.
    Difference
    0.1%
    Check dated 2024-06-06T14:31:17.000Z thumbnail image
  7. Check
    24 days ago
    Change Detected
    Summary
    The value 'Participation Criteria 6' has been updated to provide a detailed explanation of eligibility criteria, including examples such as a person's general health condition or prior treatments. This change offers more specific information about the criteria researchers use to select participants for clinical studies.
    Difference
    36%
    Check dated 2024-05-22T21:12:06.000Z thumbnail image
  8. Check
    46 days ago
    Change Detected
    Difference
    0.9%
    Check dated 2024-04-30T22:37:27.000Z thumbnail image

Stay in the know with updates to Secukinumab Efficacy in Atopic Dermatitis Clinical Trial

Enter your email address, and we'll notify you when there's something new on the Secukinumab Efficacy in Atopic Dermatitis Clinical Trial page.